Bioceres Crop Solutions Corp.
General ticker "BIOX" information:
- Sector: Materials
- Industry: Agricultural Inputs
- Capitalization: $150.4M (TTM average)
Bioceres Crop Solutions Corp. does not follow the US Stock Market performance with the rate: -32.0%.
Estimated limits based on current volatility of 5.8%: low 0.46$, high 0.51$
Factors to consider:
- Total employees count: 409 as of 2019
- Current price 90.0% below estimated low
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-06-30 to 2026-06-30
- 2024-06-30 to 2025-06-30 estimated range: [5.17$, 11.38$]
- 2025-06-30 to 2026-06-30 estimated range: [4.61$, 10.11$]
Financial Metrics affecting the BIOX estimates:
- Positive: with PPE of 179.7 at the end of fiscal year the price was very low
- Positive: 7.54 < Operating profit margin, % of 9.64
- Positive: -3.75 < Return on assets ratio (scaled to [-100,100]) of 0.73
- Negative: Operating cash flow per share per price, % of 6.16 <= 6.59
- Positive: -0.03 < Industry operating cash flow per share per price (median), % of 1.08
- Positive: 19.24 < Shareholder equity ratio, % of 36.98 <= 42.59
- Negative: Investing cash flow per share per price, % of -4.24 <= -0.60
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: Industry operating profit margin (median), % of -1.41 <= 2.88
Short-term BIOX quotes
Long-term BIOX plot with estimates
Financial data
| YTD | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating Revenue | $419.45MM | $464.83MM | $333.30MM |
| Operating Expenses | $365.26MM | $420.01MM | $337.00MM |
| Operating Income | $54.18MM | $44.82MM | $-3.70MM |
| Non-Operating Income | $-35.08MM | $-34.79MM | $-50.20MM |
| Interest Expense | $23.79MM | $26.87MM | $50.10MM |
| R&D Expense | $15.35MM | $17.18MM | $0.00MM |
| Income(Loss) | $19.11MM | $10.04MM | $-53.90MM |
| Taxes | $-1.07MM | $3.78MM | $-1.30MM |
| Net Income(Loss)* | $18.78MM | $3.24MM | $-51.80MM |
| Stockholders Equity | $298.85MM | $315.30MM | $262.81MM |
| Inventory | $140.57MM | $126.22MM | $89.99MM |
| Assets | $818.06MM | $852.55MM | $763.65MM |
| Operating Cash Flow | $2.59MM | $41.72MM | $49.91MM |
| Capital expenditure | $22.56MM | $22.78MM | $14.61MM |
| Investing Cash Flow | $-25.73MM | $-28.73MM | $-6.13MM |
| Financing Cash Flow | $32.95MM | $-10.06MM | $-50.71MM |
| Earnings Per Share** | $0.30 | $0.05 | $-0.82 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.